Last updated November 11, 2026 · Reviewed by the Gala Health team
Asynchronous vs video visits
Telehealth care for a GLP-1 can be synchronous, meaning a live video visit, or asynchronous, meaning the provider reviews your written answers and messages you. Both are real medical evaluations by a licensed provider, and in both the provider prescribes only if the medicine is appropriate. Asynchronous review is faster for you because there is no appointment to schedule.
At Gala, the choice is not yours or the website's. Gala's system decides it on the server from your state and your answers, the same way for every patient, when your assessment is submitted.
When Gala requires a video visit
| Reason | What triggers it |
|---|---|
| Your state | A few states require a live first visit. As of November 2026 they are Arkansas, Delaware, the District of Columbia, Kansas, Mississippi, New Mexico, Rhode Island and West Virginia |
| Recent birth | You gave birth in the last 6 months |
| Age plus health history | You are 65 to 74 and have kidney disease, liver disease, type 2 diabetes or a high blood pressure reading |
State rules change, and Gala updates its list when they do. If none of these apply, your review is usually asynchronous. Your provider can still ask for a video visit if they need one.
If you need a visit, you book it after checkout and complete it by video. After that first visit, follow-ups, dose adjustments and questions are usually handled by message in the Gala GLP-1 app.
What an asynchronous review looks like
- You answer the online assessment: health history, current medicines, height and weight, and your goals.
- A licensed provider typically reviews your information within 24 hours.
- If they need more detail, they message you in the Gala GLP-1 app.
- If a GLP-1 is appropriate, they prescribe it, and medication is typically prescribed and shipped within 48 hours.
- You can keep messaging your care team at no extra cost, 7 days a week.
Read the full path in how to get approved for a GLP-1 online.
Is a GLP-1 without a video visit safe?
Safety comes from the questions asked and from who reads them. Gala's assessment screens for conditions the Wegovy® and Zepbound® labels flag, such as a personal or family history of medullary thyroid cancer or MEN 2 (both labels list these as contraindications), pancreatitis (a label warning) and pregnancy (the labels say these medicines may cause fetal harm), and it stops before checkout when an answer rules a GLP-1 out. Answers that need a closer look go to the provider, and some move the patient to a video visit automatically.
In a 2026 JAMA study, Yale researchers used a simulated patient to seek a GLP-1 prescription from 49 websites. 45 offered a prescription, only 13 required a video visit and 3 a phone call, and only about half asked about eating disorders. The question that matters is what you are asked and who reads your answers. Gala's assessment asks about eating disorders and every condition listed above, and a licensed provider reviews every assessment, prescribes only if appropriate, and can message you or request a visit whenever they need more.
Start with Gala
Gala offers compounded semaglutide, compounded tirzepatide and brand-name Ozempic®. Compounded medications are not FDA-approved. Video provider visits are included when you need one, there is no membership fee, and all doses are included in your plan price.
Start your online GLP-1 assessment. If you are already on a GLP-1, see switching GLP-1 providers first.
This article is for information only and is not medical advice. Telehealth rules vary by state and can change.
Frequently asked questions
Do I need a video call to get a GLP-1 prescription online?
Usually not at Gala. By default, a licensed provider reviews your assessment and follows up by message. A video visit is required in a few states, after a birth in the last 6 months, or for patients aged 65 to 74 with certain conditions, and it is typically only for the first visit.
Which states require a video visit for a GLP-1 at Gala?
As of November 2026, Gala requires a live first visit in Arkansas, Delaware, the District of Columbia, Kansas, Mississippi, New Mexico, Rhode Island and West Virginia. State rules change, so the list can change too.
Is an asynchronous GLP-1 prescription legitimate?
Yes, where state rules allow it. A licensed provider reviews your medical history and prescribes only if it is appropriate, and can message you or request a video visit if they need more information.
Can I ask for a video visit even if I do not need one?
You can message your care team at any time and ask. Your provider decides whether a live visit is needed for your care.
Do follow-ups need video visits too?
Usually not. At Gala, if a video visit is required it is typically for the initial session, and follow-ups, dose adjustments and questions are handled through the Gala GLP-1 app.
Ready to talk to a provider?
Your answers go to a licensed provider, who decides whether treatment is right for you. Learn more about Weight Loss.
More Weight Loss guides
- compounded vs brand GLP-1
- GLP-1 and alcohol guide
- GLP-1 dosing schedule
- GLP-1 side effects guide
- switching GLP-1 providers
- how GLP-1 approval works online
- compounded GLP-1 vials vs pens
- whether the GLP-1 price goes up with the dose
- how long GLP-1 takes to work
- how to inject GLP-1
- Ozempic vs Wegovy
- semaglutide vs tirzepatide comparison
- stopping GLP-1 and weight regain
- Wegovy pill vs injection
- what to eat on GLP-1
- Zepbound vs Mounjaro
- tirzepatide pills
- GLP-1 without a membership fee
- compounded tirzepatide vs Zepbound
- compounded tirzepatide dosage chart
- compounded semaglutide dosage chart
- GLP-1 cost without insurance
- best online GLP-1 providers
- Ro vs Hims for weight loss
- Hims weight loss alternatives
Sources
- Novo Nordisk. WEGOVY (semaglutide) injection and tablets prescribing information. FDA-approved label.
- Eli Lilly. ZEPBOUND (tirzepatide) prescribing information. FDA-approved label.
- Yale School of Medicine. Secret shopper study: GLP-1 prescriptions widely available online with limited clinician oversight (Chetty AK, et al. JAMA. 2026). August 2026.
- Chetty AK, Chen AS, Ross JS, Ramachandran R. Online prescribing of GLP-1 receptor agonists. JAMA. 2026;336(5):428-431.
- Medical Xpress. GLP-1 'secret shopper' study finds gaps in online prescribing. July 2026.
This article is for general information and is not medical advice. Talk to a licensed provider about your own health.
